Dr. Lazaros J. Lekakis, MD
- Medicare services, 2024
- 233
- Medicare patients, 2024
- 77
- Part D claims, 2024
- 45
- Publications
- 88
- Clinical trials
- 10
- Practice address
- 1475 Nw 12th Ave, Miami, FL 33136
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lekakis' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Lazaros J. Lekakis is a hematologist and oncologist in Miami, Florida
Dr. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
Dr. Lekakis' NPI, 1326067596, was assigned on July 19, 2006. Dr. Lekakis graduated from University of Athens in 1995. Dr. Lekakis holds Florida license ME108303.
- NPI
- 1326067596NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0547267544
- NPI enumeration date
- July 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Lazaros J. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida
Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.
- Sylvester Comprehensive Cancer Center1475 Nw 12th Ave, Miami, FL 33136
Source: Dmand AI Affiliation Data
Dr. Lazaros J. Lekakis is affiliated with 1 site of care and 1 medical group
Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Lazaros J. Lekakis' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lekakis practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sylvester Comprehensive Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Lazaros J. Lekakis is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Lekakis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lekakis is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lekakis' licenses on file in 3 states: Florida, Kentucky and Illinois.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
- Kentucky license
- Illinois license
Clinical focus
Dmand AI lists anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Lekakis treats.
Hematologists and oncologists near Dr. Lekakis
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Lazaros J. Lekakis billed Medicare for 233 services in 2024
CMS data shows 233 Medicare services from Dr. Lekakis across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $21,981 for them.
Dr. Lekakis' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2982024: 23322%
Where Dr. Lekakis' Medicare services took place, 2024
- In an office9942%
- In a facility13458%
Dr. Lekakis compared with the Florida median for hematologists and oncologists, 2024
- Dr. Lekakis
- Florida median
- Medicare services
- 233vs 69767% below
- Medicare patients
- 77vs 21865% below
- Part D claims
- 13vs 34196% below
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Lekakis' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lekakis?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lekakis and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Lazaros J. Lekakis treated 77 Medicare patients in 2024, average age 66
CMS counts 77 Medicare patients who saw Dr. Lekakis in 2024. The largest group is 65 to 74, with 38 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lekakis' median patient age at 68, with 38% women.
Dr. Lekakis' Medicare patients by age, 2024
Dr. Lekakis' Medicare patients by sex, 2024
- Women4255%
- Men3545%
Chronic conditions among Dr. Lekakis' Medicare patients, 2024
- High blood pressure68%
- High cholesterol68%
- Arthritis44%
- Chronic kidney disease35%
- Diabetes35%
- Anxiety34%
- Mood disorders34%
- Ischemic heart disease30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lekakis' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women38%
- Men62%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Lazaros J. Lekakis wrote 45 Medicare Part D claims in 2024
In 2024, Dr. Lekakis wrote 45 Medicare Part D claims for 18 patients. 62% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2020, CMS named 17 claims across 1 drug.
Dr. Lekakis' Part D claims by kind of drug, 2024
- Generic28 claims62%
- Brand-name17 claims38%
Dr. Lekakis' most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 172021: 1324%
Drugs named by CMS: 1 in 2021, 1 in 2020.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Lazaros J. Lekakis scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lekakis for performance year 2024, reported individually. Dr. Lekakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lekakis as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Lekakis' MIPS scores, performance year 2024
- 100of 100Final score
- 93.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Lazaros J. Lekakis has 88 publications on record
Dmand AI links 88 papers to Dr. Lekakis, published from 2009 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Hematopoietic Stem Cell Transplantation, Lymphoma, Large B-Cell, Diffuse and Immunotherapy, Adoptive. Dr. Lekakis has published most often in Blood Adv. Dr. Lekakis' most frequent co-authors are Frederick Lundry Locke, MD, Amer M. Beitinjaneh, MD and Sattva S. Neelapu, MD.
Dr. Lekakis' papers by year, 2016 to 2025
Topics Dr. Lekakis writes about most
- Hematopoietic Stem Cell Transplantation
- Lymphoma, Large B-Cell, Diffuse
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
- Antigens, CD19
- Biological Products
- Transplantation, Autologous
- Antineoplastic Combined Chemotherapy Protocols
Dr. Lekakis' most frequent co-authors
- Frederick Lundry Locke, MD19 shared papers
- Amer M. Beitinjaneh, MD18 shared papers
- Sattva S. Neelapu, MD16 shared papers
Recent publications by Dr. Lekakis
Bone Marrow Transplant
See who Dr. Lekakis researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lekakis works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Lazaros J. Lekakis has worked on 10 clinical trials
Dmand AI links Dr. Lekakis to 10 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse and Anemia, Sickle Cell. Emory University sponsors the most, 2.
Clinical trials with Dr. Lekakis by phase
- 1Phase 1: 1 trial
- 2Phase 1/2: 2 trials
- 3Phase 2: 3 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Lekakis' trials
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Anemia, Sickle Cell
- Lymphoma, Non-Hodgkin
- Carcinoma, Ovarian Epithelial
Investigators on the most trials with Dr. Lekakis
- Reem Md Karmali, MD2 shared trials
- Mark Charles Walters, MO2 shared trials
- Rajni Agarwal, MD1 shared trial
Recent clinical trials with Dr. Lekakis
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) (opens in a new tab)
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Lazaros J. Lekakis received $42,989 in industry payments from 2016 to 2025
CMS Open Payments shows 206 general payments to Dr. Lekakis from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Kite Pharma, Inc. paid the most, $15,471.
General payments to Dr. Lekakis by program year, 2016 to 2025
General payments to Dr. Lekakis by kind, 2016 to 2025
- Consulting fees$33,16077%
- Food and beverage$6,78716%
- Travel and lodging$2,4236%
- Education$6191%
Companies that paid Dr. Lekakis the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Lazaros J. Lekakis has 1 award and honors on record
Dmand AI lists 1 award for Dr. Lekakis, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Lekakis
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Lazaros J. Lekakis graduated from University of Athens
Dr. Lekakis graduated from University of Athens in 1995.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Lazaros J. Lekakis accepts plans from 11 insurance carriers
Dr. Lekakis is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Elevance
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Molina
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- Cigna
- +3 more carriersWith a free account
Plan types Dr. Lekakis accepts, by number of carriers
- PPO7
- HMO5
- Medicare5
- POS5
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Lazaros J. Lekakis's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Lazaros J. Lekakis
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Lazaros J. Lekakis' NPI number?
Dr. Lazaros J. Lekakis' NPI number is 1326067596. It was assigned on July 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Lazaros J. Lekakis?
Dr. Lazaros J. Lekakis is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Lazaros J. Lekakis practice?
Dr. Lekakis practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.
What is Dr. Lazaros J. Lekakis' medical license number?
Dr. Lekakis holds Florida license ME108303, one of the licenses on file in 3 states.
Which states has Dr. Lazaros J. Lekakis been licensed in?
Dmand AI has state licenses on file for Dr. Lekakis in Florida (2010 to 2027), Kentucky (2006 to 2011) and Illinois (1999 to 2002).
Which hospitals is Dr. Lazaros J. Lekakis affiliated with?
Dr. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida.
What medical group is Dr. Lazaros J. Lekakis part of?
Dr. Lekakis is linked to University of Miami Health System.
Does Dr. Lazaros J. Lekakis accept Medicare?
Yes. CMS data shows Dr. Lekakis billed Medicare for 233 services in 2024, and Dr. Lekakis accepts Medicare assignment.
Does Dr. Lazaros J. Lekakis offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Lekakis as offering telehealth services.
What is Dr. Lazaros J. Lekakis' MIPS score?
Dr. Lekakis' MIPS final score for performance year 2024 is 100 out of 100, reported individually.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Lazaros J. Lekakis see?
CMS counts 77 Medicare patients who saw Dr. Lekakis in 2024, with an average age of 66.
Is Dr. Lazaros J. Lekakis board certified?
Yes. Dr. Lekakis is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Lazaros J. Lekakis bill to Medicare?
In 2024, Dr. Lekakis' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).
Where did Dr. Lazaros J. Lekakis go to medical school?
Dr. Lekakis graduated from University of Athens in 1995.
What drugs does Dr. Lazaros J. Lekakis prescribe most?
In 2021 Medicare Part D data, Dr. Lekakis' most prescribed drugs by claims were Zolpidem Tartrate.
Has Dr. Lazaros J. Lekakis received payments from drug or device companies?
CMS Open Payments shows $42,989 in general payments to Dr. Lekakis from 26 companies from 2016 to 2025. The largest total came from Kite Pharma, Inc.
How long has Dr. Lazaros J. Lekakis been practicing?
Dr. Lekakis graduated from medical school in 1995, 31 years ago.
Does Dr. Lazaros J. Lekakis do research?
Dmand AI links 88 publications to Dr. Lekakis, published from 2009 to 2025. Dr. Lekakis has worked on 10 clinical trials.
Who does Dr. Lazaros J. Lekakis publish with?
Dr. Lekakis' most frequent co-authors are Frederick Lundry Locke, MD (19 shared papers), Amer M. Beitinjaneh, MD (18 shared papers) and Sattva S. Neelapu, MD (16 shared papers).
What insurance does Dr. Lazaros J. Lekakis accept?
Dr. Lekakis is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card